CATX   $4.6  -5.35% Market Closed After Close 4.6 0.0

Perspective Therapeutics, Inc.
Total Cash 292.87M
totalCashPerShare 4.343
EBITDA -47.27M
Total Debt 3.88M
quickRatio 27.616
currentRatio 27.732
Total Revenue 1.46M
debtToEquity 1.136
Revenue/Share 0.034
ROA -0.12033
ROE -0.23201
grossProfits
freeCashflow -33.29M
operatingCashflow -14.17M
earningsGrowth
revenueGrowth -0.105
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -27.115969
profitMargins 0.0
enterpriseValue 507.33M
forwardPE -11.194444
floatShares 43.36M
sharesOutstanding 67.43M
sharesShort 7.88M
sharesShortPriorMonth 7.14M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.62%
Short Ratio help_outline 6.40%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 5.057
Price To Book help_outline 2.39
earningsQuarterlyGrowth
netIncomeToCommon -52.16M
trailingEps -1.47%
forwardEps -1.08%
enterpriseToEbitda -10.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.21 3Q 2024
institutionsCount 162
lastUpdated Nov. 2, 2024, 4:10 a.m.